Beta Bionics proposes $125 million underwritten public offering
Beta Bionics proposed a $125 million underwritten public offering. BBNX shares slipped 5.1% to $18.25 in after-hours Tuesday.
Beta Bionics said it proposed a $125 million underwritten public offering, sending the medical devices company’s shares lower. 25, in after-hours trading Tuesday after closing up 15%. Through the close, shares were still down 37% this year.